PITX2 and glaucoma: The glaucoma-relevant parameters that were tested in the genome-wide TM transcriptome analyses on which the present study is based, were treatments with prostaglandin analogs, transforming growth factor β, glaucoma status, and PITX2 knockdown [8-11].